Pharmacodynamics Study of Enoxalow, Produced by Blau Farmaceutica S/A, Compared to Clexane, Produced by Sanofi-Aventis Farmaceutica Ltda, in Healthy Subjects After Intravenous Administration.
Phase of Trial: Phase I
Latest Information Update: 27 Jun 2019
At a glance
- Drugs Enoxaparin sodium (Primary)
- Indications Blood coagulation disorders; Deep vein thrombosis; Embolism; Myocardial infarction; Thromboembolism; Unstable angina pectoris
- Focus Pharmacodynamics
- 03 Mar 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 02 Oct 2012 New trial record